Transient involvement of endothelin in hypertrophic remodeling of small arteries

Journal of Hypertension

Volumn 19, Issue 10, 2001, Pages 1801-1812

  Dao, Huy Hao ^a   Martens, Fabrice M A C ^d   Larivière, Richard ^b   Yamaguchi, Nobuharu ^a   Cernacek, Peter ^c   De Champlain, Jacques ^a   Moreau, Pierre ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c MONTREAL HEART INSTITUTE   (Canada)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Endothelins; Hypertrophy; Norepinephrine; Remodeling; Renin angiotensin system

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN; DARUSENTAN; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; NORADRENALIN; PRAZOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG MECHANISM; HISTOLOGY; HYPERTROPHY; MESENTERIC ARTERY; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0034804560     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200110000-00014     Document Type: Article

References (47)

1. Small artery structure in hypertension: Dual process of remodelling and growth
2. Physiological aspects of primary hypertension
3. Vascular remodeling
4. Remodeling of cerebral arterioles in chronic hypertension
5. A-receptor antagonist
6. Circulating catecholamine levels in human and experimental hypertension
7. Noradrenaline release and the pathophysiology of primary human hypertension
8. Elevated sympathetic nerve activity in borderline hypertensive humans: Evidence from direct intraneural recordings
9. The sympathetic nervous system in hypertension
10. Vascular hypertrophy and remodeling in secondary hypertension
11. Alpha1-adrenergic stimulation and beta2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells
12. Deoxycorticosterone acetate plus salt induce overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats
13. A-receptor blockade
14. Endothelin system-dependent cardiac remodeling in renovascular hypertension
15. Effects of endothelin receptor inhibition on cerebral arterioles in hypertensive rats
16. Release of endothelin from cultured bovine endothelial cells
17. B receptor antagonist
18. Oral treatment with an ETA-receptor antagonist inhibits neointima formation induced by endothelial injury
19. 2-adrenergic facilitation in the development and maintenance of DOCA-Salt hypertension
20. Effects of aging on mechanics and composition of cerebral arterioles in rats
21. A reduced elastic modulus of vascular wall components in hypertension?
22. Evidence for hyperplasia in mesenteric resistance vessels of spontaneously hypertensive rats using a 3-dimensional dissector
23. The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis
24. Simultaneous measurement of plasma catecholamine (norepinephrine, epinephrine and dopamine) and free N-methyldopamine (epinine) levels, by HPLC with electrochemical detection
25. In vivo evidence for adrenal catecholamine release mediated by nonnitinic mechanism: Local medullary effect of VIP
26. Radioreceptor assay of an endothelin A receptor antagonist in plasma and urine
27. Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats
28. Endothelin and its antagonists in hypertension: Can we foresee the future?
29. Endothelin in hypertension: A role for receptor antagonists?
30. Early, but not late-onset, endothelin-A receptor blockade can modulate hypertension, cerebral edema and proteinuria in stroke-prone hypertensive rats
31. Effects of nonpeptide endothelin receptor antagonists in rats with reduced renal mass
32. Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes
33. The effect of neonatal treatment of rats with nerve growth factor on the blood pressure and structure of the mesenteric arteries
34. Mesenteric small artery changes after vasoconstrictor infusion in young rats
35. Mechanics and composition of human subcutaneous resistance arteries in essential hypertension
36. Mechanics of cerebral arterioles in hypertensives rats
37. Pre- and postsynaptic adrenergic dysfunctions in hypertension
38. Hypertension and cardiovascular hypertrophy during chronic catecholamine infusion in rats
39. Effects of chronic norepinephrine administration on cardiac function in rats
40. Chronic intraveneous infusion of noradrenaline produces labile hypertension in conscious rats
41. Chronic alpha1-adrenoreceptor stimulation increases DNA synthesis in rat arterial wall. Modulation of responsiveness after vascular injury
42. Effects of increased pulse pressure on cerebral arterioles
43. Pheochromocytoma. Update on diagnosis, localization, and management
44. Structural vascular changes in hypertension: Role of angiotensin II, dietary sodium supplementation, blood pressure and time
45. Angiotensin II induces media hypertrophy and hyperreactivity in mesenteric but not epigastric small arteries of the rat
46. Direct effects of smooth muscle relaxation and contraction on in vivo human brachial artery elastic properties
47. Prognostic value of 24 h blood pressure variability